Uno Barcelli is a Nephrology physician. OpenAlex indexes 24 publications with 526 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4444 Austell Rd
Austell, GA 301061844
Telephone
678-460-2700Provider last certified this registry record 14 Jan 2026.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202512 payments
- Mallinckrodt Hospital Products Inc.Program year202514 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62%Angiotensin receptor blocker (ARB)9.8%Losartan Potassium82%Valsartan12%Olmesartan-Hydrochlorothiazide7%Part D<11 patientsBeta blocker8.2%Carvedilol29%Metoprolol Succinate26%Metoprolol Tartrate18%Labetalol Hcl15%Atenolol12%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
22%SGLT2 inhibitor12.3%Farxiga58%Jardiance42%Part D≥53 patientsVitamin D3 Analog4.5%Calcitriol100%Part D≥43 patients+ 5 more classes in this area
Musculoskeletal
9.1%Xanthine oxidase inhibitor9.1%Allopurinol94%Febuxostat6%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Is There a Role for Polyunsaturated Fatty Acids in the Prevention of Renal Disease and Renal Failure?
The Nephron journals/Nephron journals
2008 - Effects of Dietary Linoleic Acid Enrichment on Induction of Immune Complex Nephritis in Mice
The Nephron journals/Nephron journals
2008 - Defibrination with Ancrod: Effect on Reticuloendothelial Clearance of Circulating Immune Complexes
The Nephron journals/Nephron journals
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”